Literature DB >> 15138599

Gene expression analysis in SV40-immortalized human breast luminal epithelial cells with stem cell characteristics using a cDNA microarray.

Joon-Suk Park1, Dong-Young Noh, Seok-Hyun Kim, Sung-Hoon Kim, Gu Kong, Chia-Cheng Chang, Yong-Soon Lee, James E Trosko, Kyung-Sun Kang.   

Abstract

The epithelial compartment of the human breast comprises two distinct cell types. Type I human breast epithelial cells (HBECs) are expressing luminal epithelial cell markers and stem cell characteristics, whereas Type II HBECs show basal epithelial cell phenotypes. When defined in terms of markers for normal cell lineages, most invasive breast cancer cells correspond to the phenotype of the common luminal epithelial cell. We had developed simian virus 40-immortalized cell lines from normal HBECs with luminal and stem cell characteristics. To identify molecular changes involved in immortalization, we analyzed the differential gene expression profiles of normal and non-tumorigenic immortalized Type I HBECs using cDNA microarray with 7,448 sequence-verified clones. Out of the 7,448 genes screened, consistent gene expression changes among biological replicates included 67 in Type I HBECs and 86 in Type II HBECs for 4-fold change criteria. Surprisingly, we identified 148 genes (>2.0-fold) as being either up- or down-regulated related to immortalization: 67 genes (MYBL2, UCHL1 et al) were up-regulated, and 81 genes (IGFBP3, CDKN1A et al) were down-regulated significantly. The altered expression levels of the selected genes were subsequently confirmed by semiquantitative RT-PCR. Our studies suggest that the immortalization of Type I HBECs might be an early step in the initiation of a subset of breast cancer. Furthermore, these results will open up an avenue for more detailed understanding of breast stem cell and tumor biology.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138599

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model.

Authors:  Binwu Tang; Naomi Yoo; Mary Vu; Mizuko Mamura; Jeong-Seok Nam; Akira Ooshima; Zhijun Du; Pierre-Yves Desprez; Miriam R Anver; Aleksandra M Michalowska; Joanna Shih; W Tony Parks; Lalage M Wakefield
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

2.  Decreased Mitochondrial Mutagenesis during Transformation of Human Breast Stem Cells into Tumorigenic Cells.

Authors:  Eun Hyun Ahn; Seung Hyuk Lee; Joon Yup Kim; Chia-Cheng Chang; Lawrence A Loeb
Journal:  Cancer Res       Date:  2016-05-17       Impact factor: 12.701

3.  Neogenin expression may be inversely correlated to the tumorigenicity of human breast cancer.

Authors:  Jeong Eon Lee; Hee Joung Kim; Ji Yeon Bae; Seok Won Kim; Joon-Suk Park; Hyuk Jai Shin; Wonshik Han; Sung-Won Kim; Kyung-Sun Kang; Dong-Young Noh
Journal:  BMC Cancer       Date:  2005-12-03       Impact factor: 4.430

4.  Detection of Low-Frequency Mutations and Identification of Heat-Induced Artifactual Mutations Using Duplex Sequencing.

Authors:  Eun Hyun Ahn; Seung Hyuk Lee
Journal:  Int J Mol Sci       Date:  2019-01-08       Impact factor: 5.923

5.  Immortalization of Different Breast Epithelial Cell Types Results in Distinct Mitochondrial Mutagenesis.

Authors:  Sujin Kwon; Susan S Kim; Howard E Nebeck; Eun Hyun Ahn
Journal:  Int J Mol Sci       Date:  2019-06-08       Impact factor: 5.923

6.  Morphological and molecular characterization of the human breast epithelial cell line M13SV1 and its tumorigenic derivatives M13SV1-R2-2 and M13SV1-R2-N1.

Authors:  Sandra Stempin; Anika Engel; Nora Winkler; Thorsten Buhrke; Alfonso Lampen
Journal:  Cancer Cell Int       Date:  2015-11-25       Impact factor: 5.722

7.  Gene expression in immortalized versus primary isolated cardiac endothelial cells.

Authors:  Lisa Deng; Luisa Pollmeier; Qian Zhou; Stella Bergemann; Christoph Bode; Lutz Hein; Achim Lother
Journal:  Sci Rep       Date:  2020-02-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.